ZAGREB/LONDON, Nov 28 (Hina) - Croatia's drugs company Pliva in London on Thursday organised a Research and Development Day during which it briefed investors and analysts about the development of new products and presented its
research and development strategy, Pliva said.
ZAGREB/LONDON, Nov 28 (Hina) - Croatia's drugs company Pliva in
London on Thursday organised a Research and Development Day during
which it briefed investors and analysts about the development of
new products and presented its research and development strategy,
Pliva said. #L#
Pliva's products include those based on more than 60 generic
molecules, including 22 molecules Pliva expects to be patented and
14 molecules which have already been patented and placed on the
market.
This year Pliva has filed 552 patent requests in Europe and the
United States and received approval for the sale of 13 molecules in
Europe.
The Croatian company estimates the sales potential of newly
developed generic drugs and special products on the European market
will revolve around US$150 million in 2005, while U.S. sales also
look promising.
(hina) ha sb